Shiga toxins are the main virulence factors of a group of Escherichia coli strains [Shiga toxinproducing E. coli (STEC)] that cause severe human diseases, such as haemorrhagic colitis and haemolytic-uraemic syndrome. The Shiga toxin family comprises several toxin subtypes, which have been differentially related to clinical manifestations. In addition, the phages that carry the Shiga toxin genes (stx phages) are also diverse. These phages play an important role not only in the dissemination of Shiga toxin genes and the emergence of new STEC strains, but also in the regulation of Shiga toxin production. Consequently, differences in stx phages may affect the dissemination of stx genes as well as the virulence of STEC strains. In addition to presenting an overview of Shiga toxins and stx phages, in this review we highlight current knowledge about the diversity of stx phages, with emphasis on its impact on STEC virulence. We consider that this diversity should be taken into account when developing STEC infection treatments and diagnostic approaches, and when conducting STEC control in reservoirs.
Introduction
Shiga toxin-producing Escherichia coli (STEC) strains are a diverse group of E. coli that cause severe human diseases, such as haemorrhagic colitis and haemolytic-uraemic syndrome (HUS) (Riley et al., 1983; Karmali et al., 1985) . The latter was originally defined as a combination of renal failure, thrombocytopenia and haemolytic anaemia affecting mainly infants and children (Gianantonio et al., 1964) . Recently, the definition of HUS has come to include documented haemolysis rather than anaemia, platelet consumption rather than thrombocytopenia and signs of renal damage rather than renal failure (Ardissino et al., 2014) . HUS lacks specific treatment; HUS patients are generally given supportive care of electrolytes for water imbalance, anaemia, hypertension and renal failure (Mele et al., 2014) . The mortality rate has decreased due to improved diagnosis and treatment, yet 1-2 % of patients die during the acute phase of the disease (Loirat, 2013; Mele et al., 2014) and 30 % of patients evidence long-term renal damage (Garg et al., 2003; Spinale et al., 2013) .
Ruminants, especially bovine animals, are the main reservoir of STEC strains (Naylor et al., 2005) . These animals are asymptomatic carriers of STEC and so they generally enter the human food chain. As a result of practices during slaughtering, milking or later when handling and packaging the products, meat and milk often become the main sources of human infection in some countries (Riley et al., 1983; Bell et al., 1994; Guh et al., 2010) . Other vehicles of STEC infection include lettuce, spinach, sprouts, watercress, strawberries, apple cider, and drinking and recreational water (Robert Koch Institute, 2011; Launders et al., 2013; Luna-Gierke et al., 2014) .
We have gained a great deal of new knowledge about STEC over recent decades. However, many questions remain unanswered and some old statements need to be revised, as demonstrated in the HUS outbreak in Germany in 2011. This outbreak was caused by an unusual E. coli strain, occurred in a high proportion of adult patients and had no evidence of zoonotic origin (Frank et al., 2011; Mellmann et al., 2011; Piérard et al., 2012) . We learnt that strains lacking in typical virulence factors or belonging to infrequent serotypes may be highly virulent. Moreover, this outbreak highlighted the role of mobile elements, especially phages harbouring stx genes, in STEC virulence. In particular, regarding O26 strains from Scotland, Chase-Topping et al. (2012) suggested that stx 2 phage acquisition would increase the prevalence of those strains in severe human disease.
In this review, we analyse the published literature on the different Shiga toxin subtypes and stx phages, with special emphasis on their diversity, which can affect STEC virulence and the dissemination of Shiga toxin genes.
Shiga toxins
All STEC strains are able to produce Shiga toxins (Stx)their main virulence factor. A single STEC strain may carry one or more Shiga toxin-encoding genes (stx) in their genome. Indeed, strains carrying three or more stx subtypes have been described (Bertin et al., 2001; Eklund et al., 2002; Krüger et al., 2011) . The stx genes are generally carried by prophages (usually called stx phages or Stx phages) and the toxins are released when bacteriophage-mediated bacteriolysis occurs.
The Shiga toxin family includes several toxins related to Shiga toxin from Shigella dysenteriae that share a similar structure and biological activity. The toxins produced by STEC strains are also called verotoxins ('toxic to Vero cells'), as initially described by Konowalchuk et al. (1977) . Shiga toxins are AB5 proteins composed of one active A subunit bound to five B subunits. Their mode of action involves binding to a specific glycolipid on target cells via the B subunits followed by A subunit internalization and A1 fragment release. The RNA N-glycosidase activity of Shiga toxins inactivates 60S ribosomal subunits, leading to inhibition of protein synthesis (Endo et al., 1988; Saxena et al., 1989) . In addition, evidence shows that Shiga toxins induce apoptosis in many cell types (Tesh, 2010) .
Shiga toxin subtypes
All Shiga toxins share structural and enzymic characteristics; however, there are differences regarding sequence, biological activity and serological reactivity. Shiga toxins from E. coli are classified in two major types: Stx1 and Stx2. Each group comprises several subtypes, with the Stx2 group being more heterogeneous than the Stx1 group. The different Stx subtypes have been described over time by using different methods and criteria. This has led to a great deal of confusion about Stx nomenclature and has also hindered comparisons amongst studies performed with different subtyping approaches.
To standardize Shiga toxin nomenclature, Scheutz et al. (2012) developed a system based on phylogenetic sequencebased relatedness of the proteins. According to this scheme, the Stx nomenclature (without numbers) is reserved for Shiga toxins when they are produced by Shigella spp., and Shiga toxin subtypes found in E. coli are designated Stx1a, Stx1c, Stx1d, Stx2a, Stx2b, Stx2c, Stx2d, Stx2e, Stx2f and Stx2g. Scheutz et al. (2012) also proposed a new PCR protocol to facilitate stx subtyping standardization.
Stx subtyping is not only useful for STEC characterization, but also valuable for diagnosis as some types and subtypes of Shiga toxin have been epidemiologically associated with different clinical outcomes after STEC infection. A correlation has been observed between the stx 2 genotype and severity of disease, as several studies have shown that some stx 2 subtypes are frequently associated with a higher risk of developing HUS, whilst others are present mainly in strains isolated from patients with uncomplicated diarrhoea or in those not isolated from humans (Eklund, et al., 2002; Friedrich et al., 2002; Zhang et al., 2002; Jenkins et al., 2003; Leung et al., 2003; Beutin et al., 2004; Girardeau et al., 2005; Bielaszewska et al., 2006; Persson et al., 2007) . By applying the recently proposed nomenclature to previous studies, it is possible to correlate stx 2a with high virulence and HUS, and stx 2e , stx 2f and stx 2g with low pathogenicity in humans. However, it is not always possible to apply the current nomenclature to results of studies that used previous subtyping methods because the designations are not equivalent. Therefore, it is necessary to apply the new subtyping method and nomenclature to more studies to confirm the risk associated with each stx subtype in STEC infections and its clinical significance.
Several studies have also linked some stx subtypes to specific reservoirs. Furthermore, particular stx subtypes could affect the level of STEC shedding by cattle and consequently the risk of transmission to humans (Matthews et al., 2013) . Although most stx subtypes have been detected in STEC strains isolated from cattle and beef products, some predominate amongst bovine STEC strains whereas others are rarely detected in such strains (Bertin et al., 2001; Brett et al., 2003a; Gobius et al., 2003; Beutin et al., 2007; Krüger et al., 2011) . Examples of the latter include stx 1c , which has frequently been detected in STEC isolated from ovine faeces (Koch et al., 2001; Brett et al., 2003b) , stx 2e , the common stx subtype in STEC strains responsible for oedema disease of swine (Linggood & Thompson, 1987; Weinstein et al., 1988) , and stx 2f , detected in STEC strains isolated from the faeces of feral pigeons . Once again, it is not always possible to assign the new nomenclature to results obtained using previous subtyping methods. Future studies using the standardized protocol will contribute to confirming associations between stx subtypes and reservoirs, and enable us to gain a better understanding of the epidemiology of STEC infections.
The variability amongst Shiga toxins and stx gene sequences also has several implications for STEC detection. In some epidemiological or clinical studies, STEC presence may be underestimated when using methods that detect only a limited number of stx subtypes. To avoid this, PCR and quantitative PCR assays designed for STEC detection should include all stx subtypes and, if possible, additional identification of the stx subtypes. For example, a recent study in The Netherlands evaluated the presence of stx 2f -a generally underdiagnosed subtype. The results showed that whilst this subtype is still associated with mild STEC infections (Friesema et al., 2014), its frequency is higher than expected.
Diversity of Shiga toxin production and toxicity
Cytotoxic activity on Vero cells is a common characteristic of STEC strains due mainly to the production of Shiga toxins. However, verotoxicity assays of supernatants of STEC cultures have shown that titres vary amongst strains. Differences in cytotoxicity, Stx production or clinical outcome have been related to the number and/or type or subtype of stx genes carried by the STEC strain (Bertin et al., 2001; Eklund et al., 2002; Krüger et al., 2011) .
Despite epidemiological and experimental observations that link some stx subtypes with highly pathogenic strains, their molecular basis is not completely understood. At the same time, other factors seem to be involved. On the one A. Krü ger and P. M. A. Lucchesi hand, particular characteristics of Stx toxin, like receptorbinding affinity, have been correlated with cytotoxic specificity on different cell lines (Tyrrell et al., 1992) . In a study of potency of purified Stx toxins, Fuller et al. (2011) found differences amongst Stx subtypes under both in vitro and in vivo conditions. In particular, Stx2a and Stx2d proved more potent than Stx2b, Stx2c and Stx1. When comparing Stxs to chimeric toxins, Russo et al. (2014) found that the different toxicity between Stx1a and Stx2a on cells and in mice relies on the B subunit. On the other hand, there is diversity in stx expression amongst STEC strains, which may account for differences in virulence. Neupane et al. (2011) reported an overexpression of Stx2 in E. coli O157 : H7 strains associated with severe human disease. As discussed in the following sections, Stx production is related to the level of phage production (Köhler et al., 2000; Muniesa et al., 2003; de Sablet et al., 2008; Łoś et al., 2009) , and phages with distinct genotypes were found to produce markedly different amounts of Stx2 (Wagner et al., 1999) .
Stx phages
The role of bacteriophages in the transference of stx genes was identified in the 1980s, and phages carrying stx (here named stx phages) were soon isolated and analysed (Scotland et al., 1983; Smith et al., 1983 Smith et al., , 1984 O'Brien et al., 1984) . The first comparative studies showed a relationship between stx phages and l phages (Huang et al., 1987) . Complete sequence studies of stx phages reported at the end of the 1990s confirmed that stx phages have sequence and gene organization levels similar to those of lambdoid phages, and also showed gene clusters with related functions, including recombination, early regulation, replication, late regulation, lysis and head and tail structural gene regions (Makino et al., 1999; Miyamoto et al., 1999; Plunkett et al., 1999) . The location of stx genes within the phage lysis region, in addition to data from functional and genetic analysis of regulatory regions, indicated a link between Shiga toxin production and phage release during lytic growth (Mühldorfer et al., 1996; Neely & Friedman, 1998; Fuchs et al., 1999; Karch et al., 1999; Miyamoto et al., 1999; Plunkett et al., 1999) . Furthermore, Wagner et al. (1999) proposed an active role for stx phages in STEC pathogenesis.
Induction of stx phages
The stx phages have a phage cycle regulation similar to bacteriophage l. In the lysogenic state, the DNA of the stx phage is integrated into the STEC chromosome and the expression of most stx phage genes, including stx, is inhibited. In the absence of external inducing agents, most of the lysogens are stable; however, a small subpopulation is induced spontaneously. Under certain conditions, repression is removed, phage genes are expressed and stx phages are produced and released. This switch from the lysogenic state to the lytic state is called induction. Thus, expression of stx in STEC depends primarily on prophage induction (Wagner et al., 2001; Tyler et al., 2013) , although stx 1 transcription can be also driven by its own promoter under low iron conditions (Calderwood & Mekalanos, 1987; Aertsen et al., 2005b) .
A higher level of spontaneous induction has been reported for stx phages in comparison with non-stx phages. According to Livny & Friedman (2004) , this trait may be valuable for STEC population provided Stx production confers an advantage. The non-induced lysogens may benefit from Stx production as this toxin can cause the death of eukaryotic cells, such as unicellular predators or human leukocytes (Steinberg & Levin, 2007; Łoś et al., 2011; Mauro & Koudelka, 2011) . This supports the 'model of STEC altruism' described and analysed by Łoś et al. (2013) . Furthermore, it has been proposed that Stx has evolved as a mechanism of defence against protozoa that confers a selective advantage for bacteria harbouring stx phages (Stolfa & Koudelka, 2012) .
As in the case of l, the induction of stx prophages has been shown to be controlled by RecA (Mühldorfer et al., 1996; Fuchs et al., 1999 ) -a regulator of the SOS bacterial response. Furthermore, it is also assumed that agents or conditions that lead to bacterial DNA damage activate RecA, which cleaves the phage repressor and finally causes prophage induction. The role of RecA has also been evidenced in studies showing a higher level of spontaneous stx phage induction in recA-positive strains in comparison with recA-negative strains (Mühldorfer et al., 1996; Fuchs et al., 1999; Livny & Friedman, 2004; Imamovic & Muniesa, 2012) . Several studies have reported enhanced production of stx phage particles and Stx under typical SOS inducers, such as UV irradiation and mitomycin C. In addition to activated RecA, other mechanisms could contribute to stx prophage induction (Muniesa et al., 2004a; Imamovic & Muniesa, 2012; Nassar et al., 2013) . In a recent study, Imamovic & Muniesa (2012) described RecA-independent induction of stx 2 phages by EDTA due to its chelating property.
It is important to note that induction efficiency varies amongst the different stx prophages (Muniesa et al., 2004a; de Sablet et al., 2008; Karama & Gyles, 2008; García-Aljaro et al., 2009; Łoś et al., 2009 ). In addition, the stx phages are not equally sensitive to the different inducers.
Several factors have been shown to regulate the lysis/ lysogeny switch. Such factors include hydrogen peroxide (Wagner et al., 2001; Łoś et al., 2009 , 2010 , high temperature in combination with UV irradiation (Yue et al., 2012) , EDTA (Imamovic & Muniesa, 2012) , sodium citrate (Imamovic & Muniesa, 2012; Nejman-Faleń czyk et al., 2012) , amino acid starvation (Nejman-Faleń czyk et al., 2012) , phenethyl isothiocyanate (Nowicki et al., 2014) , DNase colicins (Toshima et al., 2007) , high hydrostatic pressure (Aertsen et al., 2005a) , sodium chloride (Łoś et al., 2009; Harris et al., 2012) , nitric oxide (Vareille et al., 2007) , 60 Co irradiation (Yamamoto et al., 2003) Ohara et al., 2002; Herold et al., 2005; Ochoa et al., 2007; Łoś et al., 2009; Nassar et al., 2013) , as well as those antibacterials used as growth promoters in animal production (Köhler et al., 2000) . The expression of stx phage genes can be regulated by the presence of other phages in the host genome (Serra-Moreno et al., 2008; and interactions amongst O157 prophages can complement the functions of defective prophages (Asadulghani et al., 2009) . Some studies show that the presence of more than one stx phage in the same strain affects Stx production in comparison with strains harbouring only one stx phage. Either an increase or a decrease in toxin production has been reported (Muniesa et al., 2003; Serra-Moreno et al., 2008; .
In addition to the characteristics of the phages, bacterial factors are also involved in the induction process. Several studies indicate a co-regulation between stx phages and the bacterial host. On the one hand, genetic and physiological conditions of the lysogen influence phage-inducing capacity (Muniesa et al., 2004a; Imamovic & Muniesa, 2012) and indeed the host effect on phage development seems to be more pronounced on stx phages than in l (Węgrzyn et al., 2014). On the other hand, stx phage lysogeny has a direct effect on the global expression of bacterial genes; moreover, an increase in acid tolerance and motility has been reported when bacteria were lysogenized (Su et al., 2010) . Tree et al. (2014) found that stx 2 bacteriophages encoded an anti-small RNA that can regulate bacterial mRNA translation. Phages can also regulate different steps of STEC interaction with the intestinal epithelium, providing a selective advantage to STEC strains for colonization and persistence. For example, Stx increases the expression of nucleolin, which is one of the receptors for intimin -an adhesin of STEC (Robinson et al., 2006) . In addition, it was described that the presence of stx 2 phages represses the type III secretion system and it was hypothesized that this repression is then overcome when appropriate niche signals are detected (Xu et al., 2012) . Tozzoli et al. (2014a) identified a regulatory region in stx phages that downregulates the expression of type III secretion, mainly present in O157 strains isolated from humans.
Diversity of stx phages
All phages carrying a stx gene are considered, by definition, stx phages. Although they commonly share several characteristics, it is not surprising that this is a heterogeneous group. The stx phages present different morphologies, e.g. a regular hexagonal head and a short tail, an elongated head and a long tail, and a regular hexagonal head and a long tail (Rietra et al., 1989; Muniesa et al., 2000; Allison et al., 2003; Karama & Gyles, 2008) . Furthermore, there is also heterogeneity in the host infectivity range (Gamage et al., 2004; Muniesa et al., 2004a) .
The genome size of sequenced stx phages ranges from 29.7 to 68.7 kb (Table 1) , with most .60 kb. Genomic differences amongst stx phages have been made evident by several approaches, including RFLP patterns (Osawa et al., 2000) , polymorphic prophage patterns (Park et al., 2013) and a multilocus characterization scheme (Smith et al., 2007) . Developments in sequencing technologies over recent years have allowed for complete nucleotide sequencing of several stx phages. Table 1 lists stx phages whose complete sequences are available in GenBank. Recent comparisons of whole genomes have confirmed that stx phages share a general genomic organization, but with a significant degree of sequence diversity, reinforcing the concept of their mosaic nature (Ahmed et al., 2012; Smith et al. 2012; Steyert et al., 2012; Cooper et al., 2014; Tozzoli et al., 2014a) . Furthermore, some studies identified different types of stx phages harbouring even the same stx 2 subtype (Ahmed et al., 2012; Tozzoli et al., 2014b) .
In an analysis of loci representing key modules involved in infection and propagation of stx phages (int, N, cI, cro, cII, Q, O, P, stx, capsid and tail structural genes, packaging), Smith et al. (2012) found a high level of genetic diversity amongst 11 stx phages as they observed that no two phages of that group possessed an identical genetic profile.
The genomes of stx phages encode many hypothetical proteins and carry genes with poorly understood roles for phage biology, mainly in the late region . Amongst others, the gene encoding a putative DNA adenine methyltransferase has been identified in some stx phages (Cooper et al., 2014) . Recently, Nübling et al.
(2014) described a functional esterase encoded downstream of the stx 2a operon in the bacteriophage 933W, and homologue genes are present in many stx 2 -encoding phages (Unkmeir & Schmidt, 2000) .
Insertion site diversity
The integration sites of stx phages in the bacterial chromosome also show great diversity. Considering the stx phages present in E. coli O157 : H7 strains, two insertion sites were first described as preferred: wrbA and yehV (Shaikh & Tarr, 2003; Besser et al., 2007) . However, there are other integration sites described for stx phages in O157, such as sbcB, argW and yecE (De Greve et al., 2002; Mellor et al., 2012; Shringi et al., 2012) .
Several integration sites have been described for stx phages in non-O157 STEC strains, i.e. argW, potC, prfC, serU, ssrA, wrbA, yciD, yecD, yecE, yjbM, ynfH and Z2577 (Recktenwald & Schmidt, 2002; Koch et al., 2003; Ahmed et al., 2012; Steyert et al., 2012; Cooper et al., 2014) .
The factors that mediate the integration of a stx phage in a specific locus have not been clearly identified and, in contrast to the immunity to superinfection of l lysogens, double lysogens have been detected (Allison et al., 2003) . In an interesting study evaluating chromosomal site specificity, Serra-Moreno et al. (2007) detected that phages preferentially use one insertion site depending on the host strain; however, if the preferred locus is unavailable, the A. Krü ger and P. M. A. Lucchesi phage integrates into a secondary insertion site. In addition, Steyert et al. (2012) observed heterogeneity in integrase genes amongst stx phages in LEE (locus of enterocyte effacement)-negative strains. Such variants could be associated with phage insertion at specific genomic locations.
Dissemination of stx phages outside the intestine
Despite the difficulties in detecting and isolating free stx phages, some studies have described their occurrence in cattle faeces, river water and sewage (Muniesa et al., 2004b; Dumke et al., 2006; Oot et al., 2007; McDonald et al., 2010) , demonstrating the circulation of these phages in the environment. It has been shown that stx phages can persist longer than their host bacteria in an aquatic environment (Muniesa et al., 1999; Allué-Guardia et al., 2014) . In addition, some stx phages have a high ability to tolerate exposure to certain disinfectants and can maintain their infectivity under food-processing conditions (Muniesa et al., 1999; Kajiura et al., 2001; Rode et al., 2011) .
Considering the role of these phages as vectors of stx genes, conditions that augment the replication and release of stx phages could facilitate the spread of stx genes. Some studies have shown that transmission of stx phages may occur in water (Imamovic et al., 2009) , in various food matrices (e.g. milk, orange juice, salad and ground beef) (Imamovic et al., 2009; Picozzi et al., 2012) and also in biofilms (Solheim et al., 2013) .
STEC strains may encounter several factors in the environment that could activate the lytic cycle of stx phages. The fact that different stx phages can be differentially induced should be taken into account in future studies to allow a better understanding of factors that enhance stx phage dissemination.
Human STEC infections and stx phages
Shiga toxins are considered the main virulence factor of STEC and it is accepted that the pathogenicity of STEC in humans depends on phage-regulated Stx production. Moreover, Tyler et al. (2013) showed that Stx2 production and disease in an enterohaemorrhagic E. coli mouse model were directly related to induction of the 933W prophage. However, the stx phage characteristics that contribute to both high virulence and variation in disease severity are poorly understood.
In a recent study, Tozzoli et al. (2014a) performed a microarray analysis of O157 STEC strains from Italy, comparing some strains isolated from human infections and others from animal sources. Interestingly, they found that the stx 2 phage was the major source of variability between the two groups. They identified two polymorphic regions, one between the gam and cII genes, associated with lytic and lysogenic cycles, and the other between roi and s.
Another phage region that shows diversity and could be related to the pathogenicity of STEC is the Q gene, which codes for a transcriptional antiterminator that controls expression of late phage genes in lambdoid phages. This gene is generally present amongst stx phages and located upstream of the stx genes (Smith et al., 2007 . Amongst the stx phages carried by O157 strains, two Q variants have been described: Q933 and Q21. Moreover, a relationship between the Q allele and the level of stx expression has been suggested (LeJeune et al., 2004; Ahmad & Zurek, 2006; Zhang et al., 2010; Mellor et al., 2012) . Recently, Steyert et al. (2012) observed phylogenetic diversity of stx phages in an analysis of Q sequences, identifying seven clusters amongst 15 selected strains. The Q sequences associated with the highest level of stx expression were found to be clustered together.
To evaluate the association between stx phage induction and disease, it is also important to take into account the possible role of intestinal factors, which may also vary amongst hosts. Currently, little is known about the effect of the specific conditions of mammalian hosts on the induction of stx prophages (Livny & Friedman, 2004; Łoś et al., 2009) . Oxidative stress has been suggested as one of the conditions that may occur in the intestine of an infected human and could influence the induction of stx phages (Łoś et al., 2010) . This idea is supported by in vitro experiments that show that hydrogen peroxide and neutrophils increase Stx2 production (Wagner et al., 2001) , and by the fact that stx phages are induced in cultures of STEC strains treated with hydrogen peroxide (Łoś et al., 2009, 2010) . However, human microbiota and their secreted products can inhibit Stx production (Gamage et al., 2003 (Gamage et al., , 2006 de Sablet et al., 2009) . Gamage et al. (2003 Gamage et al. ( , 2006 suggested that susceptibility of the intestinal flora to stx phages could exert either a protective or an antagonistic role in STEC disease and they proposed that toxin production by intestinal flora may represent another strategy of pathogenesis. Recent studies on the mechanisms that could be involved in stx expression in vivo (Bentancor et al., 2013a, b) have shown that stx 2 can be transcribed and translated in mammalian cells, producing biologically active Stx. The toxin could therefore be produced after the uptake of stx phages into eukaryotic cells, but the mechanisms by which the phages are taken up and the DNA transcribed remain unclear.
The role of stx phages in STEC pathogenicity impacts directly on therapeutic approaches to treating STEC infections. First, unlike most other bacterial infections, the treatment of human STEC infection with some antibiotics may have adverse clinical consequences (Wong et al., 2000; Zhang et al., 2000; McGannon et al., 2010) due to the effect of several antibiotics on stx phage induction and Shiga toxin production (Yee et al., 1993; Kimmitt et al., 1999 Kimmitt et al., , 2000 Matsushiro et al., 1999; Zhang et al., 2000) . Although some in vitro studies show that certain antibiotics eliminate STEC without triggering the phage lytic cycle, they do not necessarily imply the elimination of Stx production in the intestine (McGannon et al., 2010) . Additionally, several types of stx phage should be included in the studies to generalize results. Second, the phage regulation of Stx production allows the use of novel therapeutics, like anti-induction strategies, which would not be directly bactericidal, but might lessen the risk of serious complications, such as HUS (Keen, 2012) . Consequently, there are studies aimed at detecting conditions that repress phage induction. Nejman et al. (2011) have shown that plasmids derived from stx phages are not able to replicate in amino acid-starved bacteria, and Nowicki et al. (2013) have studied the mechanism responsible for the inhibition of stx phage replication under amino acid starvation, identifying the role of the ppGpp alarmone. Nejman-Faleń czyk et al. (2012) have suggested that reducing food consumption during illness, or even fasting, and providing minerals and citrate could be an option to manage STEC infections as they found that these conditions can delay and diminish the efficiency of phage particle formation. However, the authors also pointed out that such results correspond to a study involving only one phage. Bearing in mind the variability that exists amongst stx phages, more work is needed to generalize these conclusions.
Concluding remarks
In addition to Shiga toxin diversity, there is heterogeneity amongst the phages that carry stx genes and regulate their expression. Studies report differences in structure, genomic organization, response to different inducing agents and insertion site specificity. As a result, phage variability may affect the virulence of STEC strains.
In addition to its role in STEC pathogenicity, the diversity of stx phages could influence the dissemination of stx genes and the emergence of new STEC strains -events that at the same time can be promoted by other factors, such as certain environmental conditions. There is still much to learn about the virulence of STEC strains and the characteristics and behaviour of stx phages, particularly those from non-O157 strains. We consider that studies on STEC virulence and epidemiology need to take into account the diversity of Shiga toxins and stx phages, not only to choose methodological approaches but also to draw conclusions. Moreover, the variability in phage induction and Shiga toxin production should be considered when evaluating treatments for STEC infections. Cumulative effect of prophage burden on Shiga toxin production in Escherichia coli. Microbiology 158, 488-497.
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